Article citationsMore>>
Gaidano, G., Vivenza, D., Forconi, F., Capello, D., Gloghini, A., Bhatia, K., Gutierrez, M., Gallicchio, M., Avanzi, G.C., Fassone, L., Ariatti, C., Buonaiuto, D., Cingolani, A., Saglio, G., Tirelli, U., Larocca, L.M., Dalla-Favera, R. and Carbone, A. (2000) Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphomas. Genes Chromosomes Cancer, 27, 177-182.
doi:10.1002/(SICI)1098-2264(200002)27:2<177::AID-GCC9>3.0.CO;2-O
has been cited by the following article:
-
TITLE:
Bax promoter G(-248)A polymorphism in a Turkish clinical breast cancer patients: A case-control study
AUTHORS:
Yemliha Yildiz, Ilhan Yaylim, Nazli Ezgi Ozkan, Soykan Arikan, Saime Turan, Seden Kucucuk, Ender Coskunpinar, Turgay Isbir
KEYWORDS:
Bcl-2 Associated-X-Protein; SNP; Apoptosis; PCR; Susceptibility; Carcinogenesis
JOURNAL NAME:
American Journal of Molecular Biology,
Vol.3 No.1,
January
23,
2013
ABSTRACT: Bax is an important protein involved in apoptotic process. Mutations of the Bax gene are known to af- fect protein expression and function. A promotor polymorphism G(-248)A in the 5’UTR of Bax gene may alter regulation of apoptosis in carcinogenesis. Our study was performed to test the association be- tween G(-248)A polymorphisms in the Bax gene and breast cancer risk and progression. G(-248)A poly- morphism was genotyped in a Turkish breast cancer, case-control population including 53 female cancer patients (mean age ± SD: 60.9 ± 11.9 years) and 82 controls (mean age ± SD: 57.2 ± 17.5 years) using PCR-RFLP analysis. Genotype and allele frequencies were assessed with the chi-square test. There was no difference in the distribution of Bax genotypes, and allele frequencies were G (87.7% versus 88.4%) and A (12.3% versus 11.6%) in the cancer patients and controls, respectively. Within the cancer group, the presence of a polymorphic Bax G(-248)A allele was not associated with clinico-pathological parameters such as advanced tumor stage, lymph node or distant metastasis. We present the first to report on Bax G(-248)A polymorphisms in breast cancer. Our re- sults suggest that Bax G(-248)A polymorphism do not modify individual susceptibility to invasive breast cancer in Turkish women.
Related Articles:
-
Hervé A. N’cho, Innocent K. Kouame, Kouadio Koff, Lazare K. Kouassı, Séraphin K. Konan, Ruth Baï, Andrei Sandu, Ion Sandu
-
Sarah Tasneem, Lester Lipsky, Reda Ammar, Howard Sholl
-
Bernardin Ahouty, Mathurin Koffi, David Courtin, Ilboudo Hamidou, Didier Sokouri, Innocent Abé, Laure Gineau, Thomas Konan, Lingué Kouakou, Tidou Abiba Sanogo, Enock Matovu, Bruno Bucheton, Vincent Jamonneau, Simon-Pierre N’Guetta
-
Sangaré Naminata, Kouassi Edith Kwa-Koffi, Kouassi Aka Marcel, Yao Koffi Marcellin
-
Arifa Akram, Mohammad Jahidur Rahman Khan, Md. Bayzid Bin Monir, Md. Reaz Uddin Chowdhury, Mahmuda Yeasmin, Md. Maruf Ahmed Molla, Tasnim Nafisa